Viewing Study NCT04526132


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2025-12-28 @ 7:27 PM
Study NCT ID: NCT04526132
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2020-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module